CHLORPROMAZINE Side Effects

6984627-9 | Foreign Body, Orthostatic Hypotension, Vomiting
on Sep 14, 2010 Male patient from UNITED STATES , 47 years of age, weighting 172.0 lb, was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: foreign body, orthostatic hypotension, vomiting. Chlorpromazine dosage: 300mg Qid Po. During the same period patient was treated with BENZTROPINE MESYLATE (View Benztropine Mesylate Review and Benztropine Mesylate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), GEODON (View Geodon Review and Geodon Label ), LOXAPINE (View Loxapine Review and Loxapine Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), TMC (View Tmc Review and Tmc Label ), MOM (View Mom Review and Mom Label ).

6958557-2 | Protrusion Tongue, Tremor
Patient was taking Chlorpromazine (View Usage). Patient had the following side effects: protrusion tongue, tremor on Aug 30, 2010 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 150.0 lb, was diagnosed with agitation, schizophrenia and. Chlorpromazine dosage: 100mg 1x Po, 1 Dose.

6914617-3 | Bedridden, Dysphagia, Parkinsonism, Ulcer
Adverse event was reported on Aug 05, 2010 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) . Location: UNITED STATES , 76 years of age, After Chlorpromazine was administered, patient had the following side effects: bedridden, dysphagia, parkinsonism, ulcer (What is ulcer?).

6775364-4 | Incorrect Dose Administered, Orthostatic Hypotension, Tachycardia
on Jun 15, 2010 Male patient from UNITED STATES , 49 years of age, was diagnosed with hiccups and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: incorrect dose administered, orthostatic hypotension, tachycardia. Chlorpromazine dosage: 25mg Iv (only 1 Dose).


6718402-7 | Myocarditis, Overdose
on Apr 26, 2010 Female patient from INDIA , 65 years of age, was diagnosed with overdose, schizophrenia and was treated with Chlorpromazine (View Usage). Patient had the following side effects: myocarditis, overdose. Chlorpromazine dosage: Ingested In A Single Day. During the same period patient was treated with HALOPERIDOL (Ingested In A Single Day) (View Haloperidol Review and Haloperidol Label ), TRIHEXYPHENIDYL HCL (Ingested In A Single Day) (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ). Patient was hospitalized.

6702283-1 | Crepitations, Dyspnoea, Heart Rate Irregular, Hypoventilation, Loss Of Consciousness, Metabolic Acidosis, Myocarditis, Overdose, Pallor
Patient was taking Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: crepitations, dyspnoea, heart rate irregular, hypoventilation, loss of consciousness, metabolic acidosis, myocarditis, overdose, pallor on Apr 19, 2010 from INDIA Additional patient health information: Female patient , 65 years of age, was diagnosed with schizophrenia and. Chlorpromazine dosage: 1200 Mg, Unk. During the same period patient was treated with HALOPERIDOL (NGX) (80 Mg, Unk) (View Haloperidol (ngx) Review and Haloperidol (ngx) Label ), TRIHEXYPHENIDYL (NGX) (10 Mg, Unk) (View Trihexyphenidyl (ngx) Review and Trihexyphenidyl (ngx) Label ). Patient was hospitalized.

6698158-7 | Depressed Level Of Consciousness, Eating Disorder, Somnolence
Adverse event was reported on Apr 26, 2010 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) . Location: UNITED STATES , 80 years of age, weighting 194.0 lb, Patient experienced the following unwanted or unexpected effects: depressed level of consciousness, eating disorder (What is eating disorder?), somnolence. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ), PANTOPROZOLE (View Pantoprozole Review and Pantoprozole Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OXYCODONE AND ACETAMINOPHEN (View Oxycodone And Acetaminophen Review and Oxycodone And Acetaminophen Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE (View Bisoprolol Fumarate And Hydrochlorothiazide Review and Bisoprolol Fumarate And Hydrochlorothiazide Label ). Patient was hospitalized.

6662892-5 | Alveolitis Allergic, Dyspnoea, Nosocomial Infection
on Mar 18, 2010 Male patient from UNITED KINGDOM , 63 years of age, was diagnosed with depression (What is depression?) and was treated with Chlorpromazine (View Usage). Patient had the following side effects: alveolitis allergic, dyspnoea, nosocomial infection. Chlorpromazine dosage: 50 Mg, Tid. During the same period patient was treated with FLUOXETINE (60 Mg, Qd) (View Fluoxetine Review and Fluoxetine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), MIRTAZAPINE (30 Mg, Qd) (View Mirtazapine Review and Mirtazapine Label ), NAPROXEN (View Naproxen Review and Naproxen Label ). Patient was hospitalized and became disabled.

6527504-X | Abdominal Compartment Syndrome, Gastrointestinal Hypomotility, Renal Failure Acute, Shock
on Dec 22, 2009 Female patient from FRANCE , 46 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: abdominal compartment syndrome, gastrointestinal hypomotility, renal failure acute, shock. Chlorpromazine dosage: . During the same period patient was treated with LOXAPINE (View Loxapine Review and Loxapine Label ), TRIHEXYPHENIDYL HCL (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ).

6517518-8 | Abdominal Compartment Syndrome, Abdominal Distension, Abdominal Pain, Colonic Pseudo-obstruction, Gastrointestinal Hypomotility, Hypoventilation, Intestinal Resection, Renal Failure Acute, Respiratory Rate Increased
Patient was taking Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal compartment syndrome, abdominal distension, abdominal pain (What is abdominal pain?), colonic pseudo-obstruction, gastrointestinal hypomotility, hypoventilation, intestinal resection, renal failure acute, respiratory rate increased on Dec 17, 2009 from Additional patient health information: Female patient , 46 years of age, . Chlorpromazine dosage: . During the same period patient was treated with LOXAPINE (NGX) (View Loxapine (ngx) Review and Loxapine (ngx) Label ), TRIHEXYPHENIDYL (NGX) (View Trihexyphenidyl (ngx) Review and Trihexyphenidyl (ngx) Label ), TROPATEPINE (View Tropatepine Review and Tropatepine Label ). Patient was hospitalized.

6510253-1 | Tachycardia
Adverse event was reported on Dec 21, 2009 by a Female patient taking Chlorpromazine (View Usage) (Dosage: 100mg 3 Times A Day Po) . Location: UNITED STATES , weighting 139.0 lb, Patient had the following side effects: tachycardia.

6510251-8 | Tachycardia
on Dec 21, 2009 Male patient from UNITED STATES , weighting 228.2 lb, was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: tachycardia. Chlorpromazine dosage: 100mg 3 Times A Day Po.

6460543-6 | Neuroleptic Malignant Syndrome
on Nov 25, 2009 Male patient from UNITED STATES , 35 years of age, weighting 157.6 lb, was diagnosed with personality disorder (What is personality disorder?) and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: neuroleptic malignant syndrome. Chlorpromazine dosage: 100 Mg Bid Po Years. During the same period patient was treated with BENXTROPINE CONGENTIN (1mg Bid Po Years) (View Benxtropine -congentin- Review and Benxtropine -congentin- Label ), THORAZINE (View Thorazine Review and Thorazine Label ), COGENTIN (View Cogentin Review and Cogentin Label ), REMERON (View Remeron Review and Remeron Label ), CELEBREX (View Celebrex Review and Celebrex Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6436083-7 | Fatigue, Lethargy, Sedation
Patient was taking Chlorpromazine (View Usage). Patient had the following side effects: fatigue, lethargy, sedation on Nov 10, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with schizoaffective disorder and. Chlorpromazine dosage: . Patient was hospitalized.

6344871-0 | Completed Suicide
Adverse event was reported on Aug 26, 2009 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) . Location: UNITED STATES , 45 years of age, After Chlorpromazine was administered, patient had the following side effects: completed suicide. During the same period patient was treated with PYRAZOLOPYRIMIDINE (View Pyrazolopyrimidine Review and Pyrazolopyrimidine Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ).

6306445-7 | Cellulitis, Injection Site Abscess, Injection Site Anaesthesia, Injection Site Cellulitis, Injection Site Induration, Injection Site Pain, Injection Site Pustule, Injection Site Reaction, Skin Necrosis
on Aug 05, 2009 Female patient from UNITED STATES , 37 years of age, was diagnosed with migraine (What is migraine?) and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), injection site abscess, injection site anaesthesia, injection site cellulitis, injection site induration, injection site pain, injection site pustule, injection site reaction, skin necrosis. Chlorpromazine dosage: . During the same period patient was treated with PROMETHAZINE (View Promethazine Review and Promethazine Label ), VITAMIN B12 FOR INJECTION (View Vitamin B12 For Injection Review and Vitamin B12 For Injection Label ).

6182615-6 | Bladder Distension, Depression, Extrinsic Vascular Compression, Limb Discomfort, Oedema Peripheral, Pulmonary Embolism, Skin Discolouration, Stupor, Treatment Failure
on Apr 20, 2009 Male patient from JAPAN , 65 years of age, was diagnosed with depression (What is depression?) and was treated with Chlorpromazine (View Usage). Patient had the following side effects: bladder distension, depression (What is depression?), extrinsic vascular compression, limb discomfort, oedema peripheral, pulmonary embolism (What is pulmonary embolism?), skin discolouration, stupor, treatment failure. Chlorpromazine dosage: 75 Mg; Daily. During the same period patient was treated with CLOMIPRAMINE HCL (150 Mg/kg; Daily) (View Clomipramine Hcl Review and Clomipramine Hcl Label ), FLUVOXAMINE MALEATE (150 Mg; Daily; Oral) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), MIANSERIN (MIANSERIN) (20 Mg; Daily) (View Mianserin (mianserin) Review and Mianserin (mianserin) Label ), ANTIDEPRESSANTS (View Antidepressants Review and Antidepressants Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ).

6165819-8 | Bladder Distension, Depression, Extrinsic Vascular Compression, Myalgia, Oedema Peripheral, Pulmonary Embolism, Skin Discolouration, Stupor
Patient was taking Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: bladder distension, depression (What is depression?), extrinsic vascular compression, myalgia, oedema peripheral, pulmonary embolism (What is pulmonary embolism?), skin discolouration, stupor on Apr 14, 2009 from JAPAN Additional patient health information: Male patient , 65 years of age, was diagnosed with depression (What is depression?) and. Chlorpromazine dosage: 75 Mg, Daily,. During the same period patient was treated with FLUVOXAMINE MALEATE (150 Mg/day, Oral) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), SULPIRIDE (SULPIRIDE) (View Sulpiride (sulpiride) Review and Sulpiride (sulpiride) Label ), BROMAZEPAM (BROMAZEPAM) (View Bromazepam (bromazepam) Review and Bromazepam (bromazepam) Label ), ESTAZOLAM (View Estazolam Review and Estazolam Label ), BROTIZOLAM (BROTIZOLAM) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ).

6106277-9 | Bullous Lung Disease, Emphysema, Hepatic Steatosis, Hypertensive Heart Disease, Nephrosclerosis, Pleural Adhesion
Adverse event was reported on Feb 20, 2009 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: bullous lung disease, emphysema, hepatic steatosis, hypertensive heart disease, nephrosclerosis, pleural adhesion. During the same period patient was treated with AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), HYDROCODONE (HYDROCODONE) (View Hydrocodone (hydrocodone) Review and Hydrocodone (hydrocodone) Label ).

6057372-4 | Cardio-respiratory Arrest
on Jan 07, 2009 Female patient from UNITED STATES , 51 years of age, was treated with Chlorpromazine (View Usage). Patient had the following side effects: cardio-respiratory arrest. Chlorpromazine dosage: . During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ).

6057368-2 | Completed Suicide
on Jan 07, 2009 Female patient from UNITED STATES , 28 years of age, was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: completed suicide. Chlorpromazine dosage: Oral. During the same period patient was treated with VALPROIC ACID (Oral) (View Valproic Acid Review and Valproic Acid Label ), LAMOTRIGINE (Oral) (View Lamotrigine Review and Lamotrigine Label ), BACLOFEN (Oral) (View Baclofen Review and Baclofen Label ).

6027831-9 | Fibrosis, Parophthalmia
Patient was taking Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: fibrosis, parophthalmia on Dec 29, 2008 from Additional patient health information: Female patient , 59 years of age, was diagnosed with eye pain and. Chlorpromazine dosage: .

6001652-5 | Autonomic Nervous System Imbalance, Neuroleptic Malignant Syndrome
Adverse event was reported on Dec 09, 2008 by a Male patient taking Chlorpromazine (View Usage) (Dosage: 600mg) was diagnosed with schizophrenia, pulmonary tuberculosis, prophylaxis and. Location: , 42 years of age, Patient had the following side effects: autonomic nervous system imbalance, neuroleptic malignant syndrome. During the same period patient was treated with BENZTROPINE MESYLATE (1mg) (View Benztropine Mesylate Review and Benztropine Mesylate Label ), RIFAMPIN (600mg) (View Rifampin Review and Rifampin Label ), ISONIAZID (400mg) (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (1500mg) (View Pyrazinamide Review and Pyrazinamide Label ), IV HYDRATION (View Iv Hydration Review and Iv Hydration Label ). Patient was hospitalized.

5960300-0 | Angle Closure Glaucoma, Cataract, Deposit Eye, Photophobia, Visual Acuity Reduced
on Nov 03, 2008 Male patient from IRAN (ISLAMIC REPUBLIC OF) , 59 years of age, was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: angle closure glaucoma, cataract (What is cataract?), deposit eye, photophobia, visual acuity reduced. Chlorpromazine dosage: .

5959745-4 | Sinus Tachycardia
on Nov 19, 2008 Male patient from UNITED STATES , weighting 104.1 lb, was diagnosed with hiccups and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: sinus tachycardia. Chlorpromazine dosage: 25mg Po Every 8 Hrs Prn. During the same period patient was treated with AMIKACIN (View Amikacin Review and Amikacin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), DAUNORUBICIN (View Daunorubicin Review and Daunorubicin Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ), FERROUS SULFATE (View Ferrous Sulfate Review and Ferrous Sulfate Label ).

5941056-4 | Catatonia, Neuroleptic Malignant Syndrome
Patient was taking Chlorpromazine (View Usage). Patient had the following side effects: catatonia, neuroleptic malignant syndrome on Oct 28, 2008 from Additional patient health information: Female patient , 66 years of age, was diagnosed with dementia alzheimer's type, vascular dementia, parkinsonism, insomnia, catatonia and. Chlorpromazine dosage: . During the same period patient was treated with DONEPEZIL HCL (View Donepezil Hcl Review and Donepezil Hcl Label ), RISPERIDONE (2mg) (View Risperidone Review and Risperidone Label ), BENZOTROPINE (View Benzotropine Review and Benzotropine Label ), OLANZAPINE (15mg) (View Olanzapine Review and Olanzapine Label ), HYPNOTICS (View Hypnotics Review and Hypnotics Label ), LORAZEPAM (3mg) (View Lorazepam Review and Lorazepam Label ). Patient was hospitalized.

5940194-X | Abdominal Pain Upper, Abnormal Behaviour, Cholestasis, Jaundice, Nausea, Psychotic Disorder, Weight Decreased
Adverse event was reported on Oct 31, 2008 by a Female patient taking Chlorpromazine (View Usage) (Dosage: 50 Mg Tid Po) was diagnosed with bipolar disorder (What is bipolar disorder?), mania, schizoaffective disorder and. Location: UNITED STATES , 62 years of age, weighting 131.2 lb, After Chlorpromazine was administered, patient had the following side effects: abdominal pain upper, abnormal behaviour, cholestasis, jaundice (What is jaundice?), nausea (What is nausea?), psychotic disorder (What is psychotic disorder?), weight decreased. During the same period patient was treated with CARBAMAZEPINE (200 Mg Tid Po) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

5937491-0 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Glucose Increased, Blood Urea Decreased, Blood Uric Acid Increased, Delirium, Muscle Rigidity, Myoglobin Blood Increased
on Oct 22, 2008 Male patient from KOREA, REPUBLIC OF , 42 years of age, was diagnosed with schizophrenia, pulmonary tuberculosis and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood glucose increased, blood urea decreased, blood uric acid increased, delirium, muscle rigidity, myoglobin blood increased. Chlorpromazine dosage: 600mg Per Day. During the same period patient was treated with RIFAMPIN (600mg Per Day) (View Rifampin Review and Rifampin Label ), BENZTROPINE MESYLATE (1mg Per Day) (View Benztropine Mesylate Review and Benztropine Mesylate Label ), ISONIAZID (400mg Per Day) (View Isoniazid Review and Isoniazid Label ), PYRAZINAMIDE (1500mg Per Day) (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

5813575-2 | Muscle Twitching, Tardive Dyskinesia, Tic
on Jul 16, 2008 Male patient from UNITED STATES , 30 years of age, was treated with Chlorpromazine (View Usage). Patient had the following side effects: muscle twitching, tardive dyskinesia, tic (What is tic?). Chlorpromazine dosage: See Above. During the same period patient was treated with METOCLOPRAMIDE (See Above) (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

5806524-4 | Headache, Skin Discolouration
Patient was taking Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: headache (What is headache?), skin discolouration on Jul 03, 2008 from Additional patient health information: Male patient , 70 years of age, . Chlorpromazine dosage: . Patient was hospitalized.

5673988-9 | Priapism
Adverse event was reported on Mar 19, 2008 by a Male patient taking Chlorpromazine (View Usage) (Dosage: Tab Po Stat) was diagnosed with schizophrenia and. Location: UNITED STATES , 36 years of age, weighting 262.4 lb, Patient experienced the following unwanted or unexpected effects: priapism. Patient was hospitalized.

5634625-2 | Hypotension, Lethargy, Mental Status Changes
on Feb 21, 2008 Male patient from UNITED STATES , 63 years of age, was diagnosed with hiccups and was treated with Chlorpromazine (View Usage). Patient had the following side effects: hypotension, lethargy, mental status changes. Chlorpromazine dosage: 10mg Once Po. Patient was hospitalized.

5604659-2 | Balance Disorder, Blood Creatine Phosphokinase Increased, Fall, Neuroleptic Malignant Syndrome, Parkinson's Disease, Pyrexia
on Jan 24, 2008 Female patient from UNITED STATES , 60 years of age, weighting 130.1 lb, was diagnosed with bipolar disorder (What is bipolar disorder?), schizophrenia and was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: balance disorder, blood creatine phosphokinase increased, fall (What is fall?), neuroleptic malignant syndrome, parkinson's disease (What is parkinson's disease?), pyrexia. Chlorpromazine dosage: 175mg Two Divided Doses Po. During the same period patient was treated with TRIHEXYPHENIDYL HCL (2 Mg Twice Daily Po) (View Trihexyphenidyl Hcl Review and Trihexyphenidyl Hcl Label ), PRAMIPEXOLE DIHYDROCHLORIDE (View Pramipexole Dihydrochloride Review and Pramipexole Dihydrochloride Label ), RASAGILINE (View Rasagiline Review and Rasagiline Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ). Patient was hospitalized and became disabled.

5551102-8 | Acute Respiratory Distress Syndrome, Aspiration, Depressed Level Of Consciousness, Depression, Intentional Overdose, Lung Disorder
Patient was taking Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, aspiration, depressed level of consciousness, depression (What is depression?), intentional overdose, lung disorder on Dec 04, 2007 from UNITED STATES Additional patient health information: Female patient , 24 years of age, . Chlorpromazine dosage: . During the same period patient was treated with CLOZAPINE (View Clozapine Review and Clozapine Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), EFFEXOR (View Effexor Review and Effexor Label ), LUNESTA (View Lunesta Review and Lunesta Label ), SEROQUEL (View Seroquel Review and Seroquel Label ), TOPAMAX (View Topamax Review and Topamax Label ). Patient was hospitalized.

5525977-2 | Floppy Iris Syndrome, Miosis
Adverse event was reported on Nov 20, 2007 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) was diagnosed with schizophrenia and. Location: , 48 years of age, Patient had the following side effects: floppy iris syndrome, miosis.

5525452-5 | Cataract Nuclear, Floppy Iris Syndrome, Miosis, No Therapeutic Response, Posterior Capsule Rupture, Pupillary Disorder
on Nov 06, 2007 Male patient from TURKEY , 48 years of age, was diagnosed with schizophrenia and was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: cataract nuclear, floppy iris syndrome, miosis, no therapeutic response, posterior capsule rupture, pupillary disorder. Chlorpromazine dosage: 50-200mg (average Dose 100mg).

5491766-0 | Anticholinergic Syndrome, Blood Pressure Decreased, Body Temperature Decreased, Erythema, Skin Warm, Tongue Disorder
on Oct 19, 2007 Female patient from UNITED STATES , 43 years of age, was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: anticholinergic syndrome, blood pressure decreased, body temperature decreased, erythema, skin warm, tongue disorder. Chlorpromazine dosage: . During the same period patient was treated with QUETIAPINE FUMARATE (View Quetiapine Fumarate Review and Quetiapine Fumarate Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ).

5473137-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Jaundice, Liver Disorder, Liver Injury
Patient was taking Chlorpromazine (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, jaundice (What is jaundice?), liver disorder, liver injury on Sep 13, 2007 from SWEDEN Additional patient health information: Male patient , 83 years of age, was diagnosed with psychotic disorder (What is psychotic disorder?) and. Chlorpromazine dosage: .

5473130-3 | Liver Injury
Adverse event was reported on Sep 13, 2007 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: SWEDEN , 73 years of age, After Chlorpromazine was administered, patient had the following side effects: liver injury.

5415002-6 | Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Glucose Increased, Blood Lactate Dehydrogenase Increased, Gastric Lavage Abnormal, Haemoglobin Decreased, Heart Rate Increased, Hypokalaemia, Loss Of Consciousness
on Jul 30, 2007 Male patient from JAPAN , 27 years of age, was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood glucose increased, blood lactate dehydrogenase increased, gastric lavage abnormal, haemoglobin decreased, heart rate increased, hypokalaemia, loss of consciousness. Chlorpromazine dosage: 400 Mg; X1;po. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), ZOTEPINE (View Zotepine Review and Zotepine Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), BETHANECHOL CHLORIDE (View Bethanechol Chloride Review and Bethanechol Chloride Label ). Patient was hospitalized.

5400945-X | Blood Creatine Phosphokinase Increased, Depressed Level Of Consciousness, Hypokalaemia, Intentional Overdose, Metabolic Acidosis, Shock
on Jul 23, 2007 Male patient from , 27 years of age, was treated with Chlorpromazine (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, hypokalaemia, intentional overdose, metabolic acidosis, shock. Chlorpromazine dosage: 1400 Mg X 1 Dose. During the same period patient was treated with RISPERIDONE (164 Mg X 1 Dose) (View Risperidone Review and Risperidone Label ), ZOTEPINE (4350 Mg X 1 Dose) (View Zotepine Review and Zotepine Label ), VALPROIC ACID (6400 Mg X 1 Dose) (View Valproic Acid Review and Valproic Acid Label ), VETANARCOL CHLORIDE (1050 Mg X 1 Dose) (View Vetanarcol Chloride Review and Vetanarcol Chloride Label ), BROTIZOLAM (7 Mg X 1 Dose) (View Brotizolam Review and Brotizolam Label ), FLUNITRAZEPAM (56 Mg X 1 Dose) (View Flunitrazepam Review and Flunitrazepam Label ). Patient was hospitalized.

5361725-7 | Oedema Peripheral, Photosensitivity Reaction, Pruritus, Rash Erythematous, Rash Pruritic, Urticaria
Patient was taking Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: oedema peripheral, photosensitivity reaction, pruritus, rash erythematous, rash pruritic, urticaria on Jun 15, 2007 from UNITED STATES Additional patient health information: Male patient , 39 years of age, was diagnosed with bipolar disorder (What is bipolar disorder?) and. Chlorpromazine dosage: 100mg Tid Po. Patient was hospitalized.

5333897-1 | Aggression, Anticholinergic Syndrome, Cogwheel Rigidity, Confusional State, Dry Mouth, Dry Skin, Dyskinesia, Fatigue, Glossodynia
Adverse event was reported on May 07, 2007 by a Male patient taking Chlorpromazine (View Usage) (Dosage: ) was diagnosed with psychotic disorder (What is psychotic disorder?) and. Location: UNITED STATES , child 11 years of age, Patient experienced the following unwanted or unexpected effects: aggression, anticholinergic syndrome, cogwheel rigidity, confusional state, dry mouth, dry skin, dyskinesia, fatigue, glossodynia. During the same period patient was treated with RISPERIDONE (View Risperidone Review and Risperidone Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), BENZATROPINE(BENZTROPINE) (View Benzatropine(benztropine) Review and Benzatropine(benztropine) Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

5286833-0 | Activated Partial Thromboplastin Time Prolonged, Antiphospholipid Antibodies, Antiphospholipid Syndrome, Confusional State, Grand Mal Convulsion, Kaolin Cephalin Clotting Time Prolonged, Russell's Viper Venom Time Abnormal, Status Epilepticus, Thrombocytopenia
on Mar 29, 2007 Female patient from , 38 years of age, was diagnosed with schizoaffective disorder and was treated with Chlorpromazine (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, antiphospholipid antibodies, antiphospholipid syndrome, confusional state, grand mal convulsion, kaolin cephalin clotting time prolonged, russell's viper venom time abnormal, status epilepticus, thrombocytopenia. Chlorpromazine dosage: 100 Mg/day. Patient was hospitalized.

5281127-1 | Antiphospholipid Syndrome, Confusional State, Encephalopathy, Grand Mal Convulsion, Hypoventilation, Paralysis, Somnolence, Status Epilepticus, Thrombocytopenia
on Mar 13, 2007 Female patient from UNITED KINGDOM , 38 years of age, was diagnosed with schizoaffective disorder and was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: antiphospholipid syndrome, confusional state, encephalopathy, grand mal convulsion, hypoventilation, paralysis (What is paralysis?), somnolence, status epilepticus, thrombocytopenia. Chlorpromazine dosage: . Patient was hospitalized.

5232866-X | Pre-eclampsia
Patient was taking Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia on Jan 26, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 43 years of age, was diagnosed with agitation, depression (What is depression?) and. Chlorpromazine dosage: 25 Mg, 2/d. During the same period patient was treated with VENLAFAXINE HCL (75 Mg, Each Morning) (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PROZAC (20mg Mane) (View Prozac Review and Prozac Label ).

5180936-7 | Hepatitis, Hepatotoxicity
Adverse event was reported on Dec 18, 2006 by a Female patient taking Chlorpromazine (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 127.9 lb, Patient had the following side effects: hepatitis (What is hepatitis?), hepatotoxicity. During the same period patient was treated with ARIPIPRAZOLE (View Aripiprazole Review and Aripiprazole Label ).

5103606-X | Hypoaesthesia Oral
on Sep 11, 2006 Female patient from UNITED STATES , 14 years of age, weighting 171.0 lb, was treated with Chlorpromazine (View Usage). After Chlorpromazine was administered, patient had the following side effects: hypoaesthesia oral. Chlorpromazine dosage: 50 Mg Stat Im.

5101957-6 | Blood Pressure Decreased, Circulatory Collapse, Depression, Dizziness, Electrocardiogram Qt Corrected Interval Prolonged, Hallucination, Auditory, Heart Rate Increased, Loss Of Consciousness
on Aug 16, 2006 Female patient from UNITED STATES , 35 years of age, was diagnosed with schizophrenia, paranoid type, depression (What is depression?) and was treated with Chlorpromazine (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, circulatory collapse, depression (What is depression?), dizziness (What is dizziness?), electrocardiogram qt corrected interval prolonged, hallucination, auditory, heart rate increased, loss of consciousness. Chlorpromazine dosage: See Image. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.

5095314-9 | Blood Pressure Decreased, Circulatory Collapse, Dizziness, Electrocardiogram Qt Corrected Interval Prolonged, Heart Rate Increased, Loss Of Consciousness, Respiratory Rate Increased
Patient was taking Chlorpromazine (View Usage). Patient had the following side effects: blood pressure decreased, circulatory collapse, dizziness (What is dizziness?), electrocardiogram qt corrected interval prolonged, heart rate increased, loss of consciousness, respiratory rate increased on Aug 16, 2006 from UNITED STATES Additional patient health information: Female patient , 35 years of age, was diagnosed with schizophrenia, paranoid type, depression (What is depression?) and. Chlorpromazine dosage: 100 Mg, Bid; See Image. During the same period patient was treated with FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ). Patient was hospitalized.